{
    "title": "India approves Gilead's remdesivir to treat severe COVID-19 cases",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8383055/India-approves-Gileads-remdesivir-treat-severe-COVID-19-cases.html",
    "date": "2020-06-03",
    "keywords": [
        "drug",
        "use",
        "gilead",
        "remdesivir",
        "emergency",
        "covid19",
        "treatment",
        "approval",
        "bengaluru",
        "june",
        "administration",
        "india",
        "email",
        "tuesday",
        "dcgi",
        "month",
        "government",
        "hospital",
        "improvement",
        "forefront",
        "battle",
        "vaccine",
        "condition",
        "general",
        "week",
        "benefit",
        "course",
        "study",
        "fare",
        "laboratory",
        "disease",
        "authorization",
        "food",
        "health",
        "day",
        "korea",
        "swift",
        "import",
        "indias",
        "coronavirus",
        "official",
        "death",
        "toll",
        "evidence",
        "time",
        "express",
        "newspaper",
        "drugmaker",
        "share",
        "dosage",
        "statement",
        "licensing",
        "company",
        "supply",
        "july",
        "europe",
        "reporting",
        "anuron",
        "kumar",
        "mitra",
        "mishra",
        "editing",
        "louise",
        "koyyur"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}